Basma Mnif

Prof. Dr. Basma Mnif

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2013 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
BMBasma Mnif
Basma Mnif
HHHela Harhour
Hela Harhour
JJJihen Jdidi
Jihen Jdidi
FMFaouzia Mahjoubi
Faouzia Mahjoubi
NGNathalie Genel
Nathalie Genel
AHAdnene Hammami
Adnene Hammami
Extended-spectrum β-lactamases (ESBLs), particularly CTX-M- type ESBLs, are among the most important resistance determinants spreading worldwide in Enterobacteriaceae. The aim of this study was to characterize a collection of 163 ESBL-producing Escherichia coli collected in Tunisia, their ESBL-encoding plasmids and plasmid associated addiction systems. The collection comprised 163 ESBL producers collected from two university hospitals of Sfax between 1989 and 2009. 118 isolates harbored blaCTX-M gene (101 blaCTX-M-15 gene and 17 blaCTX-M-14 gene). 49 isolates carried blaSHV-12 gene, 9 blaSHV-2a gene and only 3 blaTEM-26 gene. 16 isolates produced both CTX-M and SHV-12. The 101 CTX-M-15-producing isolates were significantly associated to phylogroup B2 and exhibiting a high number of virulence factors. 24 (23.7%) of the group B2 isolates belonged to clonal complex ST131. Pulsed-field gel electrophoresis (PFGE) typing revealed a genetic diversity of the isolates. 144 ESBL determinants were transferable mostly by conjugation. The majority of plasmid carrying blaCTX-M-15 genes (72/88) were assigned to various single replicon or multireplicon IncF types and had significantly a higher frequency of addiction systems, notably the VagCD module. This study demonstrates that the dissemination of CTX-M-15 producing E. coli in our setting was due to the spread of various IncF-type plasmids harboring multiple addiction systems, into related clones with high frequency of virulence determinants.

11 May 2011 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
SKSonia Ktari
Sonia Ktari
BMBasma Mnif
Basma Mnif
FLFadoua Louati
Fadoua Louati
SRSonia Rekik
Sonia Rekik
SMSonda Mezghani
Sonda Mezghani
AHAdnane Hammami
Adnane Hammami

26 September 2012 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
BMBasma Mnif
Basma Mnif
SKSonia Ktari
Sonia Ktari
ACAnis Chaari
Anis Chaari
FMFatma Medhioub
Fatma Medhioub
FRFaouzia Rhimi
Faouzia Rhimi
AHAdnane Hammami
Adnane Hammami
To report an outbreak due to Providencia stuartii isolates carrying blaOXA-48, blaPER-1, blaCMY-4 and qnrA6 in a Tunisian hospital in 2011. Eight intensive care unit (ICU) patients infected/colonized by extended-spectrum β-lactamase (ESBL)-producing P. stuartii between March and May 2011 were included. Molecular epidemiology was studied by PFGE. Antibiotic resistance genes were analysed by PCR and sequencing and the plasmid incompatibility group by a PCR-based replicon typing scheme. Eight patients were colonized with ESBL-producing P. stuartii isolates. All these isolates were clonally related and found to carry blaOXA-48, blaPER-1, blaCMY-4, qnrA6 and aac-6′-Ib genes on the same self-conjugative IncA/C plasmid. The same strain was also cultured from environmental samples in the ICU. All these isolates were susceptible to carbapenems. Only one colonized patient developed P. stuartii pleurisy and was effectively treated with imipenem alone. This is the first report of an outbreak due to P. stuartii isolates carrying blaOXA-48 in Tunisia. The simultaneous expression of various resistance genes (blaOXA-48, blaCMY-4, blaPER-1, qnrA and aac-6′-Ib) by P. stuartii isolates is alarming.

10 October 2012 in Letters in Applied Microbiology
Verified
Journal Article
Closed access
PDF file
BMBasma Mnif
Basma Mnif
SKS. Ktari
S. Ktari
FRF.M. Rhimi
F.M. Rhimi
AHA. Hammami
A. Hammami

1 December 2017 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
SKSonia Ktari
Sonia Ktari
IJIkram Jmal
Ikram Jmal
MMManel Mroua
Manel Mroua
SMSonda Maalej
Sonda Maalej
NANourelhouda Ben Ayed
Nourelhouda Ben Ayed
AHAdnene Hammami
Adnene Hammami
To analyze the serotype distribution of Streptococcus pneumoniae clinical isolates collected in the south of Tunisia over a 5-year period in different age groups and to assess their antimicrobial susceptibility patterns. A total of 305 non-duplicate S. pneumoniae isolates were collected between January 2012 and December 2016 at the university hospital in Sfax, Tunisia. All isolates were serotyped by multiplex PCR. The antibiotic susceptibility of all isolates was determined using the disk diffusion test or Etest assay. Among the 305 pneumococcal isolates, 76 (24.9%) were invasive and 229 (75.1%) were non-invasive. The most common serotypes were 19F (20%), 14 (16.7%), 3 (9.2%), 23F (7.5%), 19A (5.9%), and 6B (5.9%). Potential immunization coverage rates for pneumococcal conjugate vaccines PCV7, PCV10, and PCV13 were 58%, 59.3%, and 78.7%, respectively. Three-quarters (75.3%) of pneumococcal isolates were non-susceptible to penicillin. The resistance rate to erythromycin was 71.4%. Only two isolates were resistant to levofloxacin. 19F and 14 were the most prevalent serotypes in the south of Tunisia. The inclusion of a PCV in the immunization program could be useful for reducing the burden of pneumococcal diseases. The high resistance rate to penicillin and macrolides is alarming. Prudent use of antibiotics is crucial to prevent the selection of multidrug-resistant pneumococci.

11 October 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
SFSana Ferjani
Sana Ferjani
EMElaa MAAMAR
Elaa MAAMAR
AFAsma Ferjani
Asma Ferjani
KMKhaoula Meftah
Khaoula Meftah
HBHajer Battikh
Hajer Battikh
IBIlhem Boutiba
Ilhem Boutiba
Background: Actually, no data on the prevalence of plasmid colistin resistance in Tunisia are available among clinical bacteria. Objectives: This study aimed to investigate the current epidemiology of colistin resistance and the spread of the mcr gene in clinical Gram-negative bacteria (GNB) isolated from six Tunisian university hospitals. Methods: A total of 836 GNB strains were inoculated on COL-R agar plates with selective screening agar for the isolation of GNB resistant to colistin. For the selected isolates, mcr genes, beta-lactamases associated-resistance genes and molecular characterisation were screened by PCRs and sequencing. Results: Colistin-resistance was detected in 5.02% (42/836) of the isolates and colistin-resistant isolates harboured an ESBL (blaCTX-M-15) and/or a carbapenemase (blaOXA-48, blaVIM) encoding gene in 45.2% of the cases. The mcr-1 gene was detected in four E. coli isolates (0.59%) causing urinary tract infections and all these isolates also contained the blaTEM-1 gene. The blaCTX-M-15 gene was detected in three isolates that also carried the IncY and IncFIB replicons. The genetic environment surrounding the mcr-carrying plasmid indicated the presence of pap-2 gene upstream mcr-1 resistance marker with unusual missing of ISApl1 insertion sequence. The Conclusions: This study reports the first description of the mcr-1 gene among clinical E. coli isolates in Tunisia and provides an incentive to conduct routine colistin susceptibility testing in GNB clinical isolates.